| Literature DB >> 30570582 |
Calvin T Sung, Maria A McGowan1, Brian C Machler2, Sharon E Jacob1.
Abstract
Allergic contact dermatitis is a common disease within the family of delayed-type hypersensitivity reactions. In more severe cases of allergic contact dermatitis, topical steroids may prove insufficient, and systemic therapeutic agents are often used. Even when systemic therapies such as cyclosporine lead to improvement, withdrawal of these agents is challenging and can lead to undesirable morbidities. Currently, there are no systemic treatments indicated for the treatment of widespread recalcitrant contact dermatitis. This review discusses the targets of in-use off-label systemic medications and potential therapeutics in the pipeline.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30570582 DOI: 10.1097/DER.0000000000000435
Source DB: PubMed Journal: Dermatitis ISSN: 1710-3568 Impact factor: 4.845